News
OCT seems to reduce periprocedural MI, a benefit not seen in the chronic coronary syndrome patients that deserves further ...
In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved ...
Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures - ...
Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the early commercial availability of its FDA-approved ROADSAVERtm Carotid Stent System. Indicated for use ...
The global market for Radial Compression Devices is forecasted to attain USD 293.8 million by 2025, expanding at 7.6% CAGR to reach USD 609.4 million by 2035. In 2024, the revenue of Radial ...
One of the most common signs of coronary artery disease is chest pain, also known as angina. This pain can feel like pressure ...
Innovation in device technology remains a key battleground, with companies seeking to reduce complication rates and procedural times. The integration of digital health tools and data analytics into ...
Before treatment patients should be recommended best medical management of their cardiovascular risks ... SILK stent (Balt, Montmorency, France) were retrospectively reviewed to assess the incidence ...
Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...
Understand Peripheral Artery Disease (PAD) and its link with hypertension. Learn about the causes, symptoms, and risks ...
University of Iowa Health Care has become the first in Iowa to offer drug-coated balloon therapy for patients with blockages ...
Deferred stenting shows no significant clinical benefits over conventional immediate percutaneous coronary intervention in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results